Monday, 19 January 2026

ESMO 2025: Prostate highlights

Dr María Natalia Gandur Quiroga gives her pick of the key prostate cancer abstracts from the European Society of Medical Oncology 2025 -this is all about improvements to standard drug treatments - however it although only 6 mins long it requires good concentration for those of us not so well versed in drug names! See it at: https://ecancer.org/en/video/12536-esmo-2025-prostate-highlights

Tuesday, 13 January 2026

At last an explanation for prostate cancer that makes more sense!

Mark Lintern, architect of the Cell Suppression Theory of Cancer shares his recent insights into the nature of prostate cancer in this great radio show.

Yes to Life write: "Prostate cancer has tended to be an anomaly amongst cancer types, failing to support even the most accurate theories, and has managed to elude rational explanation – as of course has cancer as a whole.
"Mark Lintern has recently turned his attention to this anomaly to see if he is able to explain its workings within his novel Cell Suppression Theory of cancer. His conclusion is that yes, he can explain the process of cancer within the same model as other cancers, but also that the reason its behaviour appears different is due to the signature cell metabolism that sets it apart from other tissues".

I will be sending this link to my oncologist to see what her thoughts might be regarding this.

Monday, 12 January 2026

Metformin and prostate cancer

The charity Yes to Life brought my attention to this aspect of the major UK study; the STAMPEDE trial. It recently explored whether adding metformin, a commonly used diabetes medication, to hormone therapy could improve outcomes for men starting treatment for advanced prostate cancer.

The results were not a simple yes or no.
As Yes to Life note "the study did not show a clear improvement in overall survival for most people. But it did show something quieter, and still important. Metformin helped reduce some of the physical strain that hormone therapy can place on the body, including weight gain and changes to blood sugar and cholesterol."
This is a wonderful reminder that care is not only about the tumour. It is about the whole person. The body that is carrying the treatment.
Yes to Life write: "It is also a reminder of why evidence matters. Integrative support should never be about quick fixes or promises. It should be about thoughtful, well-informed care that works alongside medical treatment, not instead of it."
If you would like to read the full article, you can find it here: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00231-1/fulltext

It is also worth mentioning that Metformin maybe takes a key role in the treatment of other cancers using off-label drugs and others to 'starve' the cancer. See more about that at: https://myunexpectedguide.blogspot.com/2018/09/can-we-starve-our-cancer.html

Friday, 2 January 2026

Say no to Palantir in the NHS


NHS England is rolling out software to run our health records from Palantir – a US spy-tech firm that has supported mass deportation in the US and enabled genocide in Gaza. 
One of Palantir’s founders is also openly against the NHS. Peter Thiel claimed it “makes people sick” and said that the British people love the NHS because we’re suffering from Stockholm syndrome.

We can’t let a company like this take control of our healthcare system. I've already sent an email to Gloucestershire Health Services - please join me in sending your health services an email.

The Good LawProject have set up a simple tool so you can find out if your local NHS trust has started using the software, and then send an email demanding they say no to Palantir. 
With the government putting NHS trusts under pressure to adopt the software, we need to act right now. 

If you want to keep Palantir out of our NHS, send an email to your local trust and Wes Streeting, secretary of state for health.

Click on ,link now:

ESMO 2025: Prostate highlights

Dr María Natalia Gandur Quiroga gives her pick of the key prostate cancer abstracts from the European Society of Medical Oncology 2025 -this...